[0] => 
    [1] => conference
    [2] => rgcon-2023
    [3] => 

RGCON 2023

RGCON 2023
Crown Plaza, Rohini 24th - 26th
February 2023
Theme Curing Cancer in Children and Adolescents - A Journey of Excellence


RGCON 2023

Dear Colleagues and Friends,

The 21st Annual RGCON is being organised by the Paediatric Haematology Oncology Department-RGCI&RC from February 24th to 26th 2023 at Crown Plaza-New Delhi, India.

The theme of the current conference is “Curing Cancer in Children and Adolescents- A Journey of Excellence”.

RGCON 2023 will witness interesting and intriguing sessions with excellent academic content given by distinguished national and international experts. It will focus on topics with practical implications for Paediatric – onco-surgeons, Radiation oncologist, paediatric oncologist , general paediatrician or clinicians , scientists, nurses and allied health professionals involved in cancer care .

The scientific programme will be an academic marathon and shall focus on covering the latest developments in paediatric oncology, from basic to clinical studies/trials. The programme will be a mix of plenary sessions, seminars, Data presentations from India and SAARC countries and western world. Other highlights shall be, meet the expert sessions, oral and poster presentations and PG quiz for fellow trainees.

It will be a promising academic treat involving an overwhelming rush of presentations, workshops, conversations, and a platform form potential meet-ups to engage with colleagues from across the globe striving towards a world free of childhood cancer.

We would like to invite and encourage all healthcare professionals involved in work on cancer in children, adolescents and young adults to join us at the upcoming RGCON 2023 and to contribute to its high scientific quality.

We look forward to seeing you at the conference and making it a huge success.

Yours sincerely,
Organising committee
RGCON 2023

Who should Attend?

  • Pediatric 

  • Oncologists

  • Pediatricians

  • Pediatric

  • Radiation 

  • Fellows

  • Orthopedic 

  • Students

  • Nurses Radiologists

  • Nuclear Medicine 

  • Pathologists

Pre Conference Workshops

  • Research Methodology Workshop

  • Pediatric Solid Tumor Workshop

  • Onco – Pathology Workshop

  • Oncology Nursing Leadership Workshop

  • Radiation Oncology Workshop

  • Onco – Nursing Workshop

  • Live Flowcytometry and MRD Workshop

  • Day to Day Hematology-Oncology for Pediatricans


For more details, please email –


  • Organizing Chairperson

    Dr Gauri Kapoor
  • Organizing Secretary

    Dr Shalini Mishra
  • Organizing Secretary

    Dr Sandeep Jain
  • Organizing Secretary

    Dr Payal Malhotra
  • Organizing Co-Secretary

    Dr Jaskaran Singh Sethi


  • Dr. Rob Pieters
    MD, PhD
    Chief Medical Officer
    (Princess Maxima Centre for Pediatric Oncology)
    Professor of Pediatric Oncology
    (University of Utrecht, Netherlands)
  • Kathy P Jones
    President of SIOP
    Professor of Pediatric Oncology
    Great Ormond Street Institute of Child Health
    (University College London)
  • Dr. Meenakshi Devidas
    PhD, MBA
    Member, St Jude Faculty
    Director, Global Analytics
  • Dr. Julia Challinor
    (RN, PhD, MS in Med anthropology)
    Secretory General of SIOP
  • Dr. Scott Howard
    MD, MSc
    The University of Tennesse Health Science Centre
    (Memphis, Tennesse)
    PDG chez Resonance
  • Dr. Vinod K Prasad
    Professor of Pediatrics
    Member of The Duke Cancer Institute
    (Durham, United States)
  • Dr. Gordan Thomas
    Professor & Head
    Pediatric Surgery and Pediatric Transplant Surgery
    Children’s Hospital at Westmead
  • Dr. Martin McCabe
    MB BChir, PhD, FRCPCH
    Clinical Senior Lecturer Pediatric
    Adolescent and Young Adult Oncology
    University of Manchester UK
  • Dr. Uma H. Athale
    MD, Professor Pediatrics
    Faculty of Health Sciences
    McMaster University, Canada
  • Dr. Vaskar Saha
    MD, FRCP, FRCPath, PhD
    Director Tata Translational Cancer Research
    Center, Kolkata
    Professor Pediatric Oncology
    University of Manchester, UK
  • Dr. Victor M. Santana
    MD, Director Global Pediatric Medicine
    St. Jude Children’s Research Hospital
    Memphis. Tennessee, United States


Abstract Submission Guidelines

Abstract Title

  • Please write the title in UPPER CASE and should be limited to 25 words.
  • Followed by authorship and Institutional affiliation
  • Preferred presentation type should be mentioned here: oral or paper or either

Abstract Text

  • Abstract should be limited to 300 words and is inclusive of sub-headings.
  • Abstracts should clearly state the following:
    • Background and Aims
    • Methods
    • Results
    • Conclusions
  • The abstract may include one table or graph.
  • Abstracts that merely state that results will be subject to rejection
  • Use only standard abbreviations. Abbreviations must be consistent and be defined on 1st usage, then use of abbreviation.
  • Disease names should be written without apostrophes, for example: Wilms tumour, Burkitt lymphoma, Hodgkin disease, etc. Please do not refer to patients by their diseases e.g., ‘Wilms tumour patients’ or ALL patients’. Instead identify them as ‘patients with Wilms tumour; and ‘patients with ALL’.
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
  • Do not begin sentences with a number – type the number in full, for example, it should be ‘Three patients….’ Instead of ‘3 patients….’.
  • ecimal points must be displayed as periods (4.89) not commas (4,89).
  • Numbers beginning with a decimal point should be preceded by a zero.
  • Periods should be used in numbers for decimal points, not commas i.e., P=0.015
  • All measurements must be in metric units.
  • An acknowledgement with an identification (unique) number shall be shared with you on receipt of your abstract. Please refer to this abstract number in all correspondence regarding the abstract. Do check your spam/ junk folder if you do not see an acknowledgement in your mailbox.
  • Please contact the conference secretariat if you do not receive acknowledgement of abstract within 3 working days of submission.
  • Please do not submit multiple copies of the same abstract.
  • If the application is not submitted in the prescribed format (as mentioned above), it will not be considered for review.


  • Abstracts presented earlier cannot be submitted unless there is significant new data.
  • Case reports and small institutional series of limited added scientific value are not encouraged.
  • Presenting authors must be a registered participant. Only abstracts of authors who have their registration process completed, by the abstract submission deadline, will be considered for review.
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  • All abstracts should be submitted and presented in English with accurate grammar and spelling of a quality suitable for publication.
  • Disclosure of Conflicts of Interest – Abstract submitters should disclose any conflict of interests while submitting the abstract.
  • Instructions for preparation of presentations will be made available on the website.

Important Information

  • Last date for abstract submission is 31st Dec 2022
  • All abstracts must be submitted by email to
  • Notification regarding acceptance of the submission will be sent to the author on the email provided while submitting the abstract.
  • The scientific committee reserves the right to accept/ reject/ assign a different presentation type to all the abstracts submitted.




Our Locations
  • Sir Chotu Ram Marg, Sector – 5, Rohini Institutional Area, Rohini, New Delhi, Delhi – 110085, India

    +91-11-47022222 | Fax +91 11 27051037

  • Squadron Leader Mahender Kumar Jain Marg, Block K, Niti Bagh, New Delhi, Delhi 110049

    +91-11-45822222 / +91-11-45822200

All © reserved to Rajiv Gandhi Cancer Institute & Research Centre
Website Designing & SEO by Techmagnate